Search research articles
Contact Us
Filters
Showing results (81-90 of 189) with videos related to
Page
of 19
Sort By:
Lymphology
|
December 15, 2011
Perinatal deaths and lymphatic system involvement: a diagnostic flow-chart applying immunohistochemical methods
C Bellini, M Rutigliani, F Boccardo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2003
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts
F Boccardo, G Lunardi, P Guglielmini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Phase II study of the pure non-steroidal antiandrogen nilutamide in prostatic cancer. Italian Prostatic Cancer Project (PONCAP)
A Decensi, D Guarneri, M C Paoletti, et al.
Oncology Reports
|
May 25, 2011
Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancer
L Miglietta, L Canobbio, D Cannata, et al.
Seminars in Oncology
|
April 1, 1989
Phase-II study of Navelbine in advanced breast cancer
L Canobbio, F Boccardo, G Pastorino, et al.
Lymphology
|
September 4, 2009
Selective D2-40 lymphatic endothelium immunoreactivity in developing human fetal skin appendages
C Bellin, E Fulcheri, M Rutigliani, et al.
Lymphology
|
March 5, 2016
LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW
G Morcaldi, T Bellini, C Rossi, et al.
The International Journal of Biological Markers
|
July 19, 2006
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
F Boccardo, A Rubagotti, M Battaglia, et al.
The Journal of Urology
|
November 1, 1989
Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men
A U Decensi, D Guarneri, P Marroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials
J G Klijn, R W Blamey, F Boccardo, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 189) with videos related to
Sort By:
Page
of 19
Lymphology
|
December 15, 2011
Perinatal deaths and lymphatic system involvement: a diagnostic flow-chart applying immunohistochemical methods
C Bellini, M Rutigliani, F Boccardo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2003
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts
F Boccardo, G Lunardi, P Guglielmini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Phase II study of the pure non-steroidal antiandrogen nilutamide in prostatic cancer. Italian Prostatic Cancer Project (PONCAP)
A Decensi, D Guarneri, M C Paoletti, et al.
Oncology Reports
|
May 25, 2011
Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancer
L Miglietta, L Canobbio, D Cannata, et al.
Seminars in Oncology
|
April 1, 1989
Phase-II study of Navelbine in advanced breast cancer
L Canobbio, F Boccardo, G Pastorino, et al.
Lymphology
|
September 4, 2009
Selective D2-40 lymphatic endothelium immunoreactivity in developing human fetal skin appendages
C Bellin, E Fulcheri, M Rutigliani, et al.
Lymphology
|
March 5, 2016
LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW
G Morcaldi, T Bellini, C Rossi, et al.
The International Journal of Biological Markers
|
July 19, 2006
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
F Boccardo, A Rubagotti, M Battaglia, et al.
The Journal of Urology
|
November 1, 1989
Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men
A U Decensi, D Guarneri, P Marroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials
J G Klijn, R W Blamey, F Boccardo, et al.
Page
of 19